點(diǎn)突變影響外顯子剪接

外顯子剪接過程


The whole process is regulated by trans-acting elements such as SR proteins, heterogeneous nuclear ribonucleoproteins, and the regulatory complex. ESE, exonic splicing enhancer; ESS, exonic splicing silencer; ISE, intronic splicing enhancer; ISS, intronic splicing silencer; ss, splice site.

文章解讀

In silico prediction of splice-altering single nucleotide variants in the human genome
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267638/

拼接機(jī)制:

(i) splicing signals, including the 5′/3′ splice site and the branch point;
(ii) splicing regulatory elements, i.e. exonic/intronic splicing enhancers/silencers;
(iii) the spliceosome and other trans-acting elements that bind to cis-acting elements.


結(jié)論:

提出兩種集成學(xué)習(xí)方法,自適應(yīng)增強(qiáng)(AdaBoost)和隨機(jī)森林,被用于構(gòu)建改進(jìn)預(yù)測的新模型。
預(yù)先計(jì)算了人類基因組中所有潛在scSNV的整體評分,并將這兩個分?jǐn)?shù)及其相應(yīng)的注釋信息作成數(shù)據(jù)庫(dbscSNV)

dbscSNV數(shù)據(jù)庫(推薦使用)

以chr22的vcf測試
annovar注釋結(jié)果篩選值大于0.6的:

dbscsnv11      0.9833  22      19950045        19950045        T       A       het     116.77  22
dbscsnv11      0.9465  22      22049783        22049783        C       T       het     151.77  14

對于內(nèi)含子內(nèi)部的位點(diǎn),目前軟件很難預(yù)測準(zhǔn)確,當(dāng)懷疑為內(nèi)含子突變引起的可變剪切時,也許可做一個RNA逆轉(zhuǎn)錄。

其他在線識別剪接工具

GeneSplicer
http://www.cbcb.umd.edu/software/GeneSplicer/gene_spl.shtml

HumanSplicingFinder
http://www.umd.be/HSF/

NetGene2
http://www.cbs.dtu.dk/services/NetGene2

NNSplice
http://www.fruitfly.org/seq_tools/splice.html

FSPLICE
http://www.softberry.com/berry.phtml?topic=fsplice&group=programs&subgroup=gfind

Augustus
http://bioinf.uni-greifswald.de/augustus/submission.php

SPANR:
http://tools.genes.toronto.edu

HSF3:
http://umd.be/HSF3/

補(bǔ)充文章:InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294755/
InterVar:2015年ACMG-AMP指南對遺傳變異的臨床解釋

對用ANNOVAR生成突變注釋信息進(jìn)行了解釋并有特定的打分,最后歸為五層分類系統(tǒng)
ACMG和AMP以來自不同數(shù)據(jù)共28個標(biāo)準(zhǔn),推薦遺傳變異使用五層分類系統(tǒng):pathogenic, likely pathogenic, uncertain significance, likely benign, and benign

?著作權(quán)歸作者所有,轉(zhuǎn)載或內(nèi)容合作請聯(lián)系作者
【社區(qū)內(nèi)容提示】社區(qū)部分內(nèi)容疑似由AI輔助生成,瀏覽時請結(jié)合常識與多方信息審慎甄別。
平臺聲明:文章內(nèi)容(如有圖片或視頻亦包括在內(nèi))由作者上傳并發(fā)布,文章內(nèi)容僅代表作者本人觀點(diǎn),簡書系信息發(fā)布平臺,僅提供信息存儲服務(wù)。

相關(guān)閱讀更多精彩內(nèi)容

友情鏈接更多精彩內(nèi)容